Apr 20, 2017 20:02 pm UTC| Business
KILGORE, Texas, April 20, 2017 -- Martin Midstream Partners L.P. (NASDAQ:MMLP) announced today it has declared a quarterly cash distribution of $0.50 per unit, or $2.00 per unit on an annualized basis, for the quarter...
Five Below Names George Hill EVP of Retail Operations
Apr 20, 2017 20:02 pm UTC| Business
PHILADELPHIA, PA , April 20, 2017 -- Five Below, Inc. (NASDAQ:FIVE), the leading retailer of extreme-value merchandise for teens, pre-teens and beyond, today announced that George Hill has been named Executive Vice...
Five Below Names George Hill EVP of Retail Operations
Apr 20, 2017 20:02 pm UTC| Business
PHILADELPHIA, PA , April 20, 2017 -- Five Below, Inc. (NASDAQ:FIVE), the leading retailer of extreme-value merchandise for teens, pre-teens and beyond, today announced that George Hill has been named Executive Vice...
VBL Therapeutics Announces Positive DSMC Review in Phase 3 GLOBE Trial Investigating VB-111 in rGBM
Apr 20, 2017 20:02 pm UTC| Business
TEL AVIV, Israel, April 20, 2017 -- VBL Therapeutics (NASDAQ:VBLT), today announced that the Independent Data Safety Monitoring Committee (DSMC) met to conduct its second safety review of the Phase 3 GLOBE Study...
VBL Therapeutics Announces Positive DSMC Review in Phase 3 GLOBE Trial Investigating VB-111 in rGBM
Apr 20, 2017 20:02 pm UTC| Business
TEL AVIV, Israel, April 20, 2017 -- VBL Therapeutics (NASDAQ:VBLT), today announced that the Independent Data Safety Monitoring Committee (DSMC) met to conduct its second safety review of the Phase 3 GLOBE Study...
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
Apr 20, 2017 20:02 pm UTC| Business
SAN DIEGO, April 20, 2017 -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and...
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
Apr 20, 2017 20:02 pm UTC| Business
SAN DIEGO, April 20, 2017 -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and...